Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Emilie R Hegelund, Lars J Kjerpeseth, Laust H Mortensen, Jannicke Igland, Trygve Berge, Mariam Anjum, Grethe S Tell & Inger Ariansen. (2022) Prevalence and Incidence Rates of Atrial Fibrillation in Denmark 2004–2018. Clinical Epidemiology 14, pages 1193-1204.
Read now
Read now
Olivia S. Costa, Bridget O’Donnell, Burcu Vardar, Khaled Abdelgawwad, Christopher W. Brescia, Nitesh Sood & Craig I. Coleman. (2021) Kidney, limb and ophthalmic complications, and death in patients with nonvalvular atrial fibrillation and type 2 diabetes prescribed rivaroxaban or warfarin: an electronic health record analysis. Current Medical Research and Opinion 37:9, pages 1493-1500.
Read now
Read now
Jennifer Davidson, Amitava Banerjee, Rutendo Muzambi, Liam Smeeth & Charlotte Warren-Gash. (2020) Validity of Acute Cardiovascular Outcome Diagnoses Recorded in European Electronic Health Records: A Systematic Review. Clinical Epidemiology 12, pages 1095-1111.
Read now
Read now
Articles from other publishers (19)
Jeffrey T. Ha, Anish Scaria, Jason Andrade, Sunil V. Badve, Peter Birks, Sarah E. Bota, Anna Campain, Ognjenka Djurdjev, Amit X. Garg, Ziv Harel, Brenda Hemmelgarn, Carinna Hockham, Matthew T. James, Meg J. Jardine, Dickson Lam, Adeera Levin, Eric McArthur, Pietro Ravani, Selena Shao, Manish M. Sood, Zhi Tan, Navdeep Tangri, Reid Whitlock, Martin Gallagher & Min Jun. (2023) Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and Canada. Kidney Medicine 5:7, pages 100675.
Crossref
Crossref
Markus Meyer, James B. Wetmore, Eric D. Weinhandl & Nicholas S. Roetker. (2023) Association of Nondihydropyridine Calcium Channel Blockers Versus β-Adrenergic Receptor Blockers With Risk of Heart Failure Hospitalization. The American Journal of Cardiology 197, pages 68-74.
Crossref
Crossref
Clare L. Atzema, Ian G. Stiell, Alice S. Chong & Peter C. Austin. (2022) Validating emergency department cardioversion procedures in provincial administrative data in Ontario, Canada. PLOS ONE 17:12, pages e0277598.
Crossref
Crossref
Hemalkumar B. Mehta, Huijun AnShirin Ardeshirrouhanifard, Mukaila A. RajiG. Caleb AlexanderJodi B. Segal. (2022) Comparative Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin Among Adults With Cancer and Atrial Fibrillation. Circulation: Cardiovascular Quality and Outcomes 15:12.
Crossref
Crossref
Min Jun, Anish Scaria, Jason Andrade, Sunil V Badve, Peter Birks, Sarah E Bota, Anna Campain, Ognjenka Djurdjev, Amit X Garg, Jeffrey Ha, Ziv Harel, Brenda Hemmelgarn, Carinna Hockham, Matthew T James, Meg J Jardine, Adeera Levin, Eric McArthur, Pietro Ravani, Selena Shao, Manish M Sood, Zhi Tan, Navdeep Tangri, Reid Whitlock & Martin Gallagher. (2022) Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study. European Heart Journal - Quality of Care and Clinical Outcomes.
Crossref
Crossref
Cezary Maciejewski, Krzysztof Ozierański, Mikołaj Basza, Piotr Lodziński, Andrzej Śliwczyński, Leszek Kraj, Maciej Janusz Krajsman, Jefte Prado Paulino, Agata Tymińska, Grzegorz Opolski, Andrzej Cacko, Marcin Grabowski & Paweł Balsam. (2022) Administrative Data in Cardiovascular Research—A Comparison of Polish National Health Fund and CRAFT Registry Data. International Journal of Environmental Research and Public Health 19:19, pages 11964.
Crossref
Crossref
Haran Yogasundaram, Sunjidatul Islam, Douglas C. Dover, Nathaniel M. Hawkins, Justin Ezekowitz, Padma Kaul & Roopinder K. Sandhu. (2022) Nationwide Study of Sex Differences in Incident Heart Failure in Newly Diagnosed Nonvalvular Atrial Fibrillation. CJC Open 4:8, pages 701-708.
Crossref
Crossref
Derek S. Chew, Flora Au, Yuan Xu, Braden J. Manns, Marcello Tonelli, Stephen B. Wilton, Brenda Hemmelgarn, Shiying Kong, Derek V. Exner & Amity E. Quinn. (2022) Geographic and temporal variation in the treatment and outcomes of atrial fibrillation: a population-based analysis of national quality indicators. CMAJ Open 10:3, pages E702-E713.
Crossref
Crossref
Lingling Fang & Xin Wang. (2022) COVID-RDNet: A novel coronavirus pneumonia classification model using the mixed dataset by CT and X-rays images. Biocybernetics and Biomedical Engineering 42:3, pages 977-994.
Crossref
Crossref
Shirin Ardeshirrouhanifard, Huijun An, Ravi K. Goyal, Mukaila A. Raji, Jodi B. Segal, G. Caleb Alexander & Hemalkumar B. Mehta. (2022) Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010–2016. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 42:5, pages 375-386.
Crossref
Crossref
Roopinder K Sandhu, Sunjidatul Islam, Douglas C Dover, Jason G Andrade, Justin Ezekowitz, Finlay A McAlister, Nathaniel M Hawkins & Padma Kaul. (2022) Concurrent use of P-glycoprotein or Cytochrome 3A4 drugs and non-vitamin K antagonist oral anticoagulants in non-valvular atrial fibrillation. European Heart Journal - Quality of Care and Clinical Outcomes 8:2, pages 195-201.
Crossref
Crossref
Pishoy Gouda, Douglas C. Dover, Anamaria Savu, Kevin Bainey, Shaun G. Goodman, Robert Welsh, Padma Kaul & Roopinder Kaur Sandhu. (2022) Long-Term Outcomes for Patients With Acute Coronary Syndrome and Nonvalvular Atrial Fibrillation. The American Journal of Cardiology 167, pages 54-61.
Crossref
Crossref
Satvir Saggi, Alain Lekoubou & Bruce Ovbiagele. (2022) Prevalence and Predictors of Stroke in Patients with Crohn's Disease: A Nationwide Study. Journal of Stroke and Cerebrovascular Diseases 31:2, pages 106258.
Crossref
Crossref
Lucie‐Marie Scailteux, Fabien Despas, Frédéric Balusson, Boris Campillo‐Gimenez, Romain Mathieu, Sébastien Vincendeau, André Happe, Emmanuel Nowak, Sandrine Kerbrat & Emmanuel Oger. (2021) Hospitalization for adverse events under abiraterone or enzalutamide exposure in real‐world setting: A French population‐based study on prostate cancer patients. British Journal of Clinical Pharmacology 88:1, pages 336-346.
Crossref
Crossref
Thomas M. Roston, Sunjidatul Islam, Nathaniel M. Hawkins, Zachary W. Laksman, Shubhayan Sanatani, Andrew D. Krahn, Roopinder Sandhu & Padma Kaul. (2022) A Population-Based Study of Unexplained/Lone Atrial Fibrillation: Temporal Trends, Management, and Outcomes. CJC Open 4:1, pages 65-74.
Crossref
Crossref
Ailish Nimmo, Retha Steenkamp, Rommel Ravanan & Dominic Taylor. (2021) Do routine hospital data accurately record comorbidity in advanced kidney disease populations? A record linkage cohort study. BMC Nephrology 22:1.
Crossref
Crossref
Edward G. Soltesz, Krish C. Dewan, Louise H. Anderson, Michael A. Ferguson & A. M. Gillinov. (2021) Improved outcomes in CABG patients with atrial fibrillation associated with surgical left atrial appendage exclusion. Journal of Cardiac Surgery 36:4, pages 1201-1208.
Crossref
Crossref
Mengyuan Lyu, Yuhui Cheng, Jian Zhou, Weelic Chong, Yili Wang, Wei Xu & Binwu Ying. (2020) Systematic evaluation, verification and comparison of tuberculosis‐related non‐coding RNA diagnostic panels. Journal of Cellular and Molecular Medicine 25:1, pages 184-202.
Crossref
Crossref
Nathaniel M. Hawkins, Patrick R. Daniele, Karin H. Humphries, Justin A. Ezekowitz, Finlay A. McAlister, Roopinder K. Sandhu & Padma Kaul. (2019) Empirical Insights When Defining the Population Burden of Atrial Fibrillation and Oral Anticoagulation Utilization Using Administrative Data. Canadian Journal of Cardiology 35:10, pages 1412-1415.
Crossref
Crossref